Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 77 records per page: next > | last >>
pages: 1 2 3 4 5 ... 74 75 76 77 presentations: 1 to 50 of 3849
Overview of the Scott M. Hammer Workshop for New Investigators and Trainees   (ABSTRACT 1)
Serena S. Spudich
Yale University, New Haven, CT, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
The Evolving HIV Landscape: From the Unimaginable to the Imaginable Cure
Adam Castillejo
The London Patient, London, UK
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in Molecular Virology at CROI 2024
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in SARS-CoV-2 and HIV Immunology at CROI 2024
Elizabeth Connick
University of Arizona, Tucson, AZ, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in HIV Cure at CROI 2024
Afam A. Okoye
Oregon Health and Sciences University, Portland, OR, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in HIV Prevention at CROI 2024
LaRon E Nelson
Yale University, New Haven, CT, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in Pediatric HIV at CROI 2024
Jennifer Jao
Northwestern University, Chicago, IL, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
From Early-Stage Investigator to Change Agent: Thoughts on Maximizing the Impact of Your Career
Jeanne M. Marrazzo
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Claudia P. Cortes
University of Chile, Santiago, Chile
Rajesh T. Gandhi
Massachusetts General Hospital, Boston, MA, USA
Overview of the Case-Based Workshop on Antiretroviral Therapy
Claudia P. Cortes
University of Chile, Santiago, Chile
Overview of the Case-Based Workshop on Antiretroviral Therapy
Rajesh T. Gandhi
Massachusetts General Hospital, Boston, MA, USA
Panel Discussion
Anchalee Avihingsanon
HIV-NAT, Bangkok, Thailand
Panel Discussion
Loice A. Ombajo
University of Nairobi, Nairobi, Kenya
Panel Discussion
Anton L. Pozniak
Chelsea and Westminster Hospital, London, UK
Panel Discussion
Janine M. Trevillyan
Doherty Institute for Infection and Immunity, Melbourne, Australia
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Discussion with Audience Questions and Answers
David L. Wyles
Denver Health Medical Center, Denver, CO, USA
Annie Luetkemeyer
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Steatotic Liver Disease in Persons Living With HIV   (ABSTRACT 6)
Jennifer C. Price
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Hepatitis Delta: What to Know, What to Do?   (ABSTRACT 7)
Kathrin van Bremen
University of Bonn, Bonn, Germany
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Cirrhosis Management   (ABSTRACT 8)
Mazen Noureddin
Houston Methodist Hospital, Houston, TX, USA
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Exploring Strategies to Measure and Understand Users' Preferences in HIV Prevention and Care   (ABSTRACT 10)
Christine Tagliaferri Rael
University of Colorado Anschutz Medical Campus, Aurora, CO, USA
from CROI 2024 on March 3, 2024 2:40 PM-3:15 PM
Hybrid Effectiveness Implementation Studies: Unrecognized Challenges and Emerging Directions   (ABSTRACT 11)
Elvin H. Geng
Washington University in St Louis, St Louis, MO, USA
from CROI 2024 on March 3, 2024 2:40 PM-3:15 PM
Stopping Clinical Trials Early: When and Why   (ABSTRACT 12)
Sally Hunsberger
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2024 on March 3, 2024 2:40 PM-3:15 PM
Cryoelectron Microscopy-Based Polyclonal Epitope Mapping (cryoEMPEM)   (ABSTRACT 2)
Gabriel Ozorowski
The Scripps Research Institute, La Jolla, CA, USA
from CROI 2024 on March 3, 2024 3:00 PM-3:30 PM
A Spotlight on HIV: Visualizing Post-Entry Events by Correlative Light and Electron Microscopy   (ABSTRACT 3)
Barbara Müller
Heidelberg University, Heidelberg, Germany
from CROI 2024 on March 3, 2024 3:00 PM-3:30 PM
Single-Virus Tracking: Capturing Fast, 3-Dimensional Viral Dynamics in Live Tissue Models   (ABSTRACT 4)
Kevin Welsher
Duke University, Durham, NC, USA
from CROI 2024 on March 3, 2024 3:00 PM-3:30 PM
Single-Cell Multi-Omics of HIV Cellular Reservoirs   (ABSTRACT 5)
Iain C. Clark
University of California Berkeley, Berkeley, CA, USA
from CROI 2024 on March 3, 2024 3:00 PM-3:30 PM
Welcome from the CROI 2024 Program Committee Chair
Landon Myer
University of Cape Town, Cape Town, South Africa
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Recognition of Dr Adaora Adimora and Others We Have Lost
Diane V. Havlir
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Introduction of the Bernard Fields Lecture
Richard A. Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Modern Vaccinology: A Legacy of HIV Research   (ABSTRACT 13)
Barney S. Graham
Morehouse School of Medicine, Atlanta, GA, USA
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Introduction of the N'Galy-Mann Lecture
Landon Myer
University of Cape Town, Cape Town, South Africa
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Reflections on Ending Pediatric HIV: Back to Basics, Confront the Unexpected, Challenge Assumptions   (ABSTRACT 14)
Dorothy Mbori-Ngacha
United Nations Children Fund (former), Nairobi, Kenya
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Introduction of the Martin Delaney Presentation
Grace Kumwenda
AIDS Vaccine Advocacy Coalition (AVAC)
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Unveiling the Power of Uganda's LGBTIQ Advocacy in Shaping HIV Response and Health Care Access   (ABSTRACT 15)
Frank Mugisha
Sexual Minorities Uganda, SMUG
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
Conclusion of Opening Session and Welcome to Opening Reception
Nicolas Chomont
Université de Montréal, Montreal, Canada
from CROI 2024 on March 3, 2024 5:00 PM-7:00 PM
CROI Program Committee Chair Welcome to Monday
Landon Myer
University of Cape Town, Cape Town, South Africa
from CROI 2024 on March 4, 2024 8:30 AM-9:30 AM
What's New in HIV Vaccines: Vaccine-Induced Immune Responses   (ABSTRACT 16)
Juliana M. McElrath
Fred Hutchison Cancer Center, Seattle, WA, USA
Elizabeth Connick
University of Arizona, Tucson, AZ, USA
from CROI 2024 on March 4, 2024 8:30 AM-9:30 AM
Shall We Reach Human Papillomavirus Elimination in the Face of Inequity?   (ABSTRACT 17)
Nelly R. Mugo
Kenya Medical Research Institute, Nairobi, Kenya
Ruanne V. Barnabas
Massachusetts General Hospital, Boston, MA, USA
from CROI 2024 on March 4, 2024 8:30 AM-9:30 AM
INTRODUCTIONS (Part 1)
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Single Dose Administration of MK-8527, a Novel nRTTI, in Adults With HIV-1   (ABSTRACT 115)
Russ P. Carstens
Merck & Co., Inc.
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Antiviral Activity, Safety, and Pharmacokinetics of GS-1720: A Novel Weekly Oral InSTI   (ABSTRACT 116)
Carl J. Fichtenbaum
University of Cincinnati, Cincinnati, OH, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
VH3810109 (N6LS) in Adults With HIV-1 Who Are ART-Naive-: Phase IIa BANNER Efficacy Data   (ABSTRACT 117)
Jan Losos
ViiV Healthcare, Research Triangle Park, NC, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
A First-in-Human Study of the Trispecific HIV-1 Broadly Neutralizing Antibody, SAR441236   (ABSTRACT 118)
Athe Tsibris
Brigham and Women's Hospital, Boston, MA, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
QUESTIONS AND ANSWERS (Part 1)
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
INTRODUCTIONS (Part 2)
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Safety and Efficacy of VRC07-523LS Plus Long-Acting Cabotegravir in the Phase II ACTG A5357 Trial   (ABSTRACT 119)
Babafemi Taiwo
Northwestern University, Chicago, IL, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Lenacapavir Plus bNAbs for People With HIV and Sensitivity to Either Teropavimab or Zinlirvimab   (ABSTRACT 120)
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Therapeutic Efficacy of a Triple Combination of HIV-1 Broadly Neutralizing Antibodies   (ABSTRACT 121)
Boris D. Juelg
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Randomized Trial of Cabotegravir and Rilpivirine Long-Acting in Africa (CARES): Week 48 Results   (ABSTRACT 122)
Nicholas Paton
London School of Hygiene & Tropical Medicine, London, UK
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
QUESTIONS AND ANSWERS (Part 2)
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
INTRODUCTIONS (Part 1)
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Phase I Safety, Tolerability and Pharmacokinetics of Tenofovir Alafenamide Implants in African Women   (ABSTRACT 123)
Tanuja N. Gengiah
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Final Results of ANRS 174 DOXYVAC: A Randomized Trial to Prevent STI in MSM on PrEP   (ABSTRACT 124)
Jean-Michel G. Molina
University of Paris-Est, Paris, France
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Sustained Reduction of Bacterial STIs During the DoxyPEP Study Open-Label Extension   (ABSTRACT 125)
Annie Luetkemeyer
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
Doxycycline PEP: High Uptake and Significant Decline in STIs After Clinical Implementation   (ABSTRACT 126)
Hyman M. Scott
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
QUESTIONS AND ANSWERS (Part 1)
from CROI 2024 on March 4, 2024 10:00 AM-12:00 PM
<< first | < prev page: of 77 records per page: next > | last >>
pages: 1 2 3 4 5 ... 74 75 76 77 presentations: 1 to 50 of 3849